Indication
Amiphos is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including alkylating agents (e.g. cyclophosphamide) and platinum-containing agents (e.g. cisplatin). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amiphos is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer.
Note
Precaution
- Amiphos is a prescription drug and should be used under proper medical guidance and advice.
- Hypotension during infusion.
- Caution when used during Pregnancy and Lactation.